LANE HEIDI ALEXANDRA,BACHMANN FELIX,BREULEUX MADLAINA,BOUTROS MICHAEL,GILBERT DANIEL,ZHANG XIAN
申请号:
IN6558/CHENP/2013
公开号:
IN2013CN06558A
申请日:
2013.08.14
申请国别(地区):
IN
年份:
2015
代理人:
摘要:
Use of BUBR1 as a biomarker for predicting the response to a compound preferably resistance of a disease such as cancer in a subject wherein the compound is a furazanobenzimidazole compound of general formula (I).